186 related articles for article (PubMed ID: 32103589)
21. Loss of DNA Damage Response in Neuroblastoma and Utility of a PARP Inhibitor.
Takagi M; Yoshida M; Nemoto Y; Tamaichi H; Tsuchida R; Seki M; Uryu K; Nishii R; Miyamoto S; Saito M; Hanada R; Kaneko H; Miyano S; Kataoka K; Yoshida K; Ohira M; Hayashi Y; Nakagawara A; Ogawa S; Mizutani S; Takita J
J Natl Cancer Inst; 2017 Nov; 109(11):. PubMed ID: 29059438
[TBL] [Abstract][Full Text] [Related]
22. PARP1 expression in soft tissue sarcomas is a poor-prognosis factor and a new potential therapeutic target.
Bertucci F; Finetti P; Monneur A; Perrot D; Chevreau C; Le Cesne A; Blay JY; Mir O; Birnbaum D
Mol Oncol; 2019 Jul; 13(7):1577-1588. PubMed ID: 31131495
[TBL] [Abstract][Full Text] [Related]
23. BLM germline and somatic PKMYT1 and AHCY mutations: Genetic variations beyond MYCN and prognosis in neuroblastoma.
Novak EM; Halley NS; Gimenez TM; Rangel-Santos A; Azambuja AM; Brumatti M; Pereira PL; Vince CS; Giorgi RR; Bendit I; Cristofani LM; Odone-Filho V
Med Hypotheses; 2016 Dec; 97():22-25. PubMed ID: 27876123
[TBL] [Abstract][Full Text] [Related]
24. ABCC1 G2012T single nucleotide polymorphism is associated with patient outcome in primary neuroblastoma and altered stability of the ABCC1 gene transcript.
Pajic M; Murray J; Marshall GM; Cole SP; Norris MD; Haber M
Pharmacogenet Genomics; 2011 May; 21(5):270-9. PubMed ID: 21317832
[TBL] [Abstract][Full Text] [Related]
25. Programmed expression of pro-apoptotic BMCC1 during apoptosis, triggered by DNA damage in neuroblastoma cells.
Islam MS; Takano R; Yokochi T; Akter J; Nakamura Y; Nakagawara A; Tatsumi Y
BMC Cancer; 2019 Jun; 19(1):542. PubMed ID: 31170959
[TBL] [Abstract][Full Text] [Related]
26. Let-7e Suppresses DNA Damage Repair and Sensitizes Ovarian Cancer to Cisplatin through Targeting PARP1.
Xiao M; Guo J; Xie L; Yang C; Gong L; Wang Z; Cai J
Mol Cancer Res; 2020 Mar; 18(3):436-447. PubMed ID: 31722968
[TBL] [Abstract][Full Text] [Related]
27. Polymorphisms in poly (ADP-ribose) polymerase-1 (PARP1) promoter and 3' untranslated region and their association with PARP1 expression in breast cancer patients.
Zhai L; Li S; Li H; Zheng Y; Lang R; Fan Y; Gu F; Guo X; Zhang X; Fu L
Int J Clin Exp Pathol; 2015; 8(6):7059-71. PubMed ID: 26261599
[TBL] [Abstract][Full Text] [Related]
28. Phosphatase 1 Nuclear Targeting Subunit Mediates Recruitment and Function of Poly (ADP-Ribose) Polymerase 1 in DNA Repair.
Wang F; Zhu S; Fisher LA; Wang L; Eurek NJ; Wahl JK; Lan L; Peng A
Cancer Res; 2019 May; 79(10):2526-2535. PubMed ID: 30733193
[TBL] [Abstract][Full Text] [Related]
29. Lymph node metastasis of gastric cancer is associated with the interaction between poly (ADP-ribose) polymerase 1 and matrix metallopeptidase 2.
Kim J; Pyun JA; Cho SW; Lee K; Kwack K
DNA Cell Biol; 2011 Dec; 30(12):1011-7. PubMed ID: 21612407
[TBL] [Abstract][Full Text] [Related]
30. Poly (ADP-ribose) polymerase 1 mRNA levels strongly correlate with the prognosis of myelodysplastic syndromes.
Diamantopoulos P; Zervakis K; Zervakis P; Sofotasiou M; Vassilakopoulos T; Kotsianidis I; Symeonidis A; Pappa V; Galanopoulos A; Solomou E; Kodandreopoulou E; Papadopoulou V; Korkolopoulou P; Mantzourani M; Kyriakakis G; Viniou NA
Blood Cancer J; 2017 Feb; 7(2):e533. PubMed ID: 28212373
[TBL] [Abstract][Full Text] [Related]
31. Replication of GWAS-identified neuroblastoma risk loci strengthens the role of BARD1 and affirms the cumulative effect of genetic variations on disease susceptibility.
Capasso M; Diskin SJ; Totaro F; Longo L; De Mariano M; Russo R; Cimmino F; Hakonarson H; Tonini GP; Devoto M; Maris JM; Iolascon A
Carcinogenesis; 2013 Mar; 34(3):605-11. PubMed ID: 23222812
[TBL] [Abstract][Full Text] [Related]
32. Mechanistic insight into the role of Poly(ADP-ribosyl)ation in DNA topology modulation and response to DNA damage.
Matkarimov BT; Zharkov DO; Saparbaev MK
Mutagenesis; 2020 Feb; 35(1):107-118. PubMed ID: 31782485
[TBL] [Abstract][Full Text] [Related]
33. ATR prevents Ca
Li Z; Wang-Heaton H; Cartwright BM; Makinwa Y; Hilton BA; Musich PR; Shkriabai N; Kvaratskhelia M; Guan S; Chen Q; Yu X; Zou Y
FASEB J; 2021 May; 35(5):e21373. PubMed ID: 33811702
[TBL] [Abstract][Full Text] [Related]
34. Association of haplotype and linkage disequilibrium of PARP1 polymorphisms rs1136410, rs1805405 and rs3219088 with gallbladder cancer.
Anjali K; Kumar T; Kar AG; Kumar P; Narayan G; Singh S
Dig Liver Dis; 2023 Jun; 55(6):807-814. PubMed ID: 36581511
[TBL] [Abstract][Full Text] [Related]
35. PARP inhibitors enhance replication stress and cause mitotic catastrophe in MYCN-dependent neuroblastoma.
Colicchia V; Petroni M; Guarguaglini G; Sardina F; Sahún-Roncero M; Carbonari M; Ricci B; Heil C; Capalbo C; Belardinilli F; Coppa A; Peruzzi G; Screpanti I; Lavia P; Gulino A; Giannini G
Oncogene; 2017 Aug; 36(33):4682-4691. PubMed ID: 28394338
[TBL] [Abstract][Full Text] [Related]
36. Glioma risk associates with polymorphisms of DNA repair genes, XRCC1 and PARP1.
Yosunkaya E; Kucukyuruk B; Onaran I; Gurel CB; Uzan M; Kanigur-Sultuybek G
Br J Neurosurg; 2010 Oct; 24(5):561-5. PubMed ID: 20868244
[TBL] [Abstract][Full Text] [Related]
37. NF-κB and Poly (ADP-ribose) Polymerase 1 Form a Positive Feedback Loop that Regulates DNA Repair in Acute Myeloid Leukemia Cells.
Li D; Luo Y; Chen X; Zhang L; Wang T; Zhuang Y; Fan Y; Xu J; Chen Y; Wu L
Mol Cancer Res; 2019 Mar; 17(3):761-772. PubMed ID: 30559256
[TBL] [Abstract][Full Text] [Related]
38. Association of DNA repair gene polymorphisms with response to platinum-based doublet chemotherapy in patients with non-small-cell lung cancer.
Shiraishi K; Kohno T; Tanai C; Goto Y; Kuchiba A; Yamamoto S; Tsuta K; Nokihara H; Yamamoto N; Sekine I; Ohe Y; Tamura T; Yokota J; Kunitoh H
J Clin Oncol; 2010 Nov; 28(33):4945-52. PubMed ID: 20940192
[TBL] [Abstract][Full Text] [Related]
39. The HSF1-PARP13-PARP1 complex facilitates DNA repair and promotes mammary tumorigenesis.
Fujimoto M; Takii R; Takaki E; Katiyar A; Nakato R; Shirahige K; Nakai A
Nat Commun; 2017 Nov; 8(1):1638. PubMed ID: 29158484
[TBL] [Abstract][Full Text] [Related]
40. Perhexiline maleate enhances antitumor efficacy of cisplatin in neuroblastoma by inducing over-expression of NDM29 ncRNA.
Vella S; Penna I; Longo L; Pioggia G; Garbati P; Florio T; Rossi F; Pagano A
Sci Rep; 2015 Dec; 5():18144. PubMed ID: 26674674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]